AS4-30666-99717
3 vaccinations
3 coded responses
38 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 500 / IA
- Registered
- 2021-03-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-25
Registered in v-safe
-
2021-03-25
Dose 1 — Pfizer-BioNTech
-
2021-03-25
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-03-26
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Nausea, Abdominal painAdult check-in
- 2021-03-27
-
2021-03-28
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Headache, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-29
-
2021-03-30
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-03-31
- 2021-04-01
- 2021-04-08
-
2021-04-15
Dose 2 — Pfizer-BioNTech
-
2021-04-15
Survey response — day 0, dose 2MedDRA: Dizziness — Feeling: Fair · Headache, NauseaFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Poor · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Extreme dizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-04-19
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-04-20
- 2021-04-21
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-05-27
- 2021-10-14
- 2022-04-15
-
2022-08-01
Dose 3 — Pfizer-BioNTech
- 2022-08-01
-
2022-08-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2022-08-03
- 2022-08-04
- 2022-08-05
-
2022-08-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2022-08-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2022-08-08
Survey response — day 7, dose 3MedDRA: Flushing — Feeling: Good · FeverFree text: Flushed faceMedDRA releases: 2024-11 · check-in free text available
- 2022-08-15
- 2022-08-22
- 2022-08-29
- 2022-09-05
- 2022-09-12
- 2022-10-31
- 2023-02-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-25 | Pfizer-BioNTech | |
| 2 | 2021-04-15 | Pfizer-BioNTech | |
| 3 | 2022-08-01 | Pfizer-BioNTech | No |
Free text
Release 7 — day 0, dose 2
Systemic reaction (other): Dizziness
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Extreme dizziness
Release 12 — day 7, dose 3
Systemic reaction (other): Flushed face
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Flushing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release